[在患有复发性/阻断性扩散性大B细胞淋巴瘤的患者中,结合胺和DICE治疗方案的疗效和生存分析]
Li-Li Wu1, Li Shi1, Wei-Jing Li1
1Department of Hematology, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei Province, China.
Zhongguo shi yan xue ye xue za zhi
|May 6, 2025
概括
与DICE疗法相结合的奇达米德在治疗复发性/耐药性扩散性大B细胞淋巴瘤 (R/R DLBCL) 中显示出有效性. 密切监测血液学不良事件对于接受这种治疗的患者至关重要.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
相关概念视频
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
98
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
98


